Yahoo Web Search

  1. Yahoo Finance Results

  2. Flexion Therapeutics Inc (NASDAQ: FLXN) announced preliminary Q4 results, expecting revenues of $9.5 million, up 36 percent quarter-over-quarter. Revenues for 2018 are expected to be $22.5 million ...

  3. Why Novavax's Stock Is Surging Today

    Motley Fool via Yahoo FinanceJan 04 14:24 PM

    Shares of the clinical-stage vaccine developer Novavax (NASDAQ: NVAX) rose by more than 11% on heavy volume in premarket trading today. Novavax's shares are surging in response to a positive ...

  4. GOVX: A Preventive and Therapeutic Portfolio

    Zacks Small Cap Research via Yahoo FinanceJan 02 15:15 PM

    Over the last few years, GeoVax has expanded from a single program developing an HIV vaccine to a platform company that is using its modified vaccinia Ankara virus-like particles (MVA-VLP ...

  5. Here's Why Agenus Shares Rose as Much as 13.5% Today

    Motley Fool via Yahoo FinanceJan 03 21:22 PM

    Shares of Agenus (NASDAQ: AGEN) soared over 13% higher today after the company announced a vaccine manufacturing partnership with Phyton Biotech for QS-21, one of Agenus' vaccine ...

  6. Why GameStop, Novavax, and Epizyme Jumped Today

    Motley Fool via Yahoo FinanceJan 04 21:27 PM

    Friday was an exceptional day for the stock market, as major indexes regained all of the ground they lost in Thursday's volatile session. The December employment report from the Department of ...

  7. We would like to remind investors that BioThrax is Emergent’s key Biodefense product and is the sole vaccine to be marketed for the general use of both pre-exposure prophylaxis and post-exposure ...

  8. Here's Why Dynavax Technologies Slid 19% in December

    Motley Fool via Yahoo FinanceJan 07 13:17 PM

    What happened Shares of Dynavax Technologies (NASDAQ: DVAX), a small biopharmaceutical company struggling to launch a new hepatitis B vaccine and develop a new cancer therapy, fell 19% ...

  9. Moderna (MRNA) Announces Pipeline Progress, Shares Rise

    Zacks via Yahoo FinanceJan 09 15:04 PM

    Moderna, Inc. MRNA announced positive updates on its pipeline of immuno-oncology and rare-disease candidates at the Annual J.P. Morgan Healthcare Conference in San Francisco. The company’s pipeline ...

  10. Moderna Soars After Update of Its Pipeline Programs

    GuruFocus.com via Yahoo FinanceJan 09 17:13 PM

    Moderna is a developer of candidates for messenger RNA-based vaccines and treatments that can be used in various therapies in immuno-oncology and rare disease areas. Warning! GuruFocus ...

  11. Biotech deal flow is continuing in the new year following Thursday's announcement of Bristol-Myers Squibb Co (NYSE: BMY)'s proposed -billion acquisition of Celgene Corporation (NASDAQ: CELG) ...